MedTrace Logo

Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease

NCT00781950 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2016-12-12

Study results available
· View outcomes & findings →

Summary

This Clinical Trial is being conducted to study how patients with peripheral arterial disease (a condition in which the blood vessels of the extremities are affected) respond to a dietary regimen of flaxseed. The purpose of the study is to examine whether or not dietary flaxseed have any effect on improving symptoms of cardiovascular disease. Additionally, the effects of dietary flaxseed on exercise tolerance will be assessed.

Conditions

  • Peripheral Arterial Disease

Interventions

DIETARY_SUPPLEMENT

Flaxseed

30 grams of milled flaxseed per day in food products or on its own.

DIETARY_SUPPLEMENT

Placebo

Wheat and Mixed Dietary Oils

Sponsors & Collaborators

  • Dr. Grant Pierce

    lead OTHER

Principal Investigators

  • Grant Pierce, PhD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2011-03-31
Completion
2016-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00781950 on ClinicalTrials.gov